biotin labeled rbcs

Cell therapyexperimental

Clinical trial activity

5 trials · 7 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Jun 1, 2008 (NCT00731588)

Timeline

2000s

  1. Jan 1, 2008

    Earliest Phase 2 Sponsor(trial)

2010s

  1. Jan 1, 2013

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • Unspecified targetTissue restoration

    Tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • biotin labeled cells
  • biotin labeled rbcs
  • biotin rbcs

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT03073070Phase 1Apr 30, 2017University of Iowa
NCT02757898Phase 1Apr 1, 2016Emory University
NCT02077751Phase 1May 1, 2013National Heart, Lung, and Blood Institute (NHLBI), University of Iowa
NCT01204216N/ASep 1, 2010Department of Veteran Affairs, University of Cincinnati
NCT00731588Phase 2Jun 1, 2008National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Thrasher Research Fund, University of Iowa
Showing 5 of 5 trials
Page 1 / 1

Organizations

Research & Development (7)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
University of IowaAcademic/Hospital3322008
National Heart, Lung, and Blood Institute (NHLBI)Government2022008
Department of Veteran AffairsGovernment1112010
Emory UniversityAcademic/Hospital1112016
National Institutes of Health (NIH)Government1012008
Thrasher Research FundAcademic/Hospital1012008
University of CincinnatiAcademic/Hospital1012010
7 organizations
Page 1 / 1